Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk
JACC: Cardiovascular Interventions · 2024-11 · 17 (22) · 2664-2677
DOI: 10.1016/j.jcin.2024.08.030 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2024-11. Verfasst von Marco Roffi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Absorbable Implants, Coronary Artery Disease, Diabetes Mellitus, Drug-Eluting Stents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
- Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland; Faculty of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland. Electronic address: https://twitter.com/antonioland…
- Department of Clinical Research, University of Bern, Bern, Switzerland.
- Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland.
- Institut Cardiovasculaire Paris Sud, Ramsay Santé, Massy, France.
- Department of Interventional Cardiology, Maastricht University Medical Center, Maastricht, the Netherlands.
Zitieren
APA
Roffi, M., Landi, A., Heg, D., Frigoli, E., Chalkou, K., Chevalier, B., Ijsselmuiden, A. J. J., Kastberg, R., Komiyama, N., Morice, M. C., Onuma, Y., Ozaki, Y., Peace, A., Pyxaras, S., Sganzerla, P., Williams, R., Xaplanteris, P., Vranckx, P., Windecker, S., …, & MASTER DAPT Investigators (2024). Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk. JACC: Cardiovascular Interventions, 17(22), 2664-2677. https://doi.org/10.1016/j.jcin.2024.08.030
Vancouver
Roffi M, Landi A, Heg D, Frigoli E, Chalkou K, Chevalier B, et al. Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk. JACC: Cardiovascular Interventions. 2024;17(22):2664-2677. doi:10.1016/j.jcin.2024.08.030
BibTeX
@article{Roffi2024,
author = {Roffi, Marco and Landi, Antonio and Heg, Dik and Frigoli, Enrico and Chalkou, Konstantina and Chevalier, Bernard and Ijsselmuiden, Alexander J J and Kastberg, Robert and Komiyama, Nobuyuki and Morice, Marie-Claude and Onuma, Yoshinobu and Ozaki, Yukio and Peace, Aaron and Pyxaras, Stylianos and Sganzerla, Paolo and Williams, Rupert and Xaplanteris, Panagiotis and Vranckx, Pascal and Windecker, Stephan and Smits, Pieter C and Valgimigli, Marco and MASTER DAPT Investigators, MASTER DAPT Investigators},
title = {Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {22},
pages = {2664--2677},
doi = {10.1016/j.jcin.2024.08.030}
}
EUVIMED